AUSPERBIO
Summary
Clinical‐stage biopharma company focused on oligonucleotide therapies aiming at a functional cure for chronic hepatitis B (CHB).
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 37 M
Avg. Deal Size£ 37 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
